drugset
drugset / Trial / NCT05837156

A Clinical Study to Evaluate Cyclopofol Injection for the Prevention of Postoperative Nausea and Vomiting

NCT05837156 ↗

Phase 1 Unknown 300 enrolled Mengchang Yang
RandomizedSingle-groupOpen-labelPrevention

Summary

This study uses cyclopropofol as a positive control and adopts a large sample, multicenter, randomized, single-blind, positive parallel control test design to explore the clinical application value of cyclopropofol in preventing postoperative nausea and vomiting.

Timeline

Start
2023-08-02
Primary completion
2023-10-01
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophenol Unknown 0.4 mg/kg Other
Subject Cyclophenol Unknown 0.8 mg/kg Other
Subject Heptaflurane Unknown 0.5 % Inhaled
Subject Heptaflurane Unknown 1.5 % Inhaled
Subject Heptaflurane Unknown 2 % Inhaled

Indications

No indication recorded.